GlobalPetIndex Market Insight · Translated and expanded from · Originally published 2026-08-21 (event held 2026-08-20, Shanghai) · Lighthouse Factory claim verified against Xinhua, China News Service Shanghai, China News Weekly, and Eastday.
Summary
On 20 August 2026, Royal Canin (a Mars, Inc. brand) held its “·” (Toward the New · Toward the Heart) 2026 China Brand Summit in Shanghai before 700+ pet-health ecosystem partners. China GM Xu Juan , Global R&D Innovation Director Yann Queau, Greater Retail & Breeding Channels Director Xiao Lei , and Corporate Affairs Director Vivian outlined three breakthroughs — Nutrition, Manufacturing, and Ecosystem.
58 Years of Precision Nutrition
Founded in 1968 (France), Royal Canin has developed 600+ dry and wet formulas globally and offers 350+ nutritional combinations for China, covering the full life cycle from breeding through senior years. The brand frames its mission around the “unmet needs” of dogs and cats — e.g., its cardiac prescription diet for feline hypertrophic cardiomyopathy (HCM, affecting ~15% of cats), where a clinical study of 44 subclinical HCM cats showed improved cardiac biomarkers and ventricular-wall thickness returning toward normal (<6mm) over 6–12 months.
Breakthrough 1 — Nutrition
Global R&D director Yann Queau presented the philosophy “Based on science, starting from dogs and cats.” Highlights:
- 76 kibble shapes and multiple wet-food textures, each engineered for breed, jaw structure, and health need. The 11+ senior cat formula reduces kibble hardness by 8.82% vs. the indoor adult formula and adds the HealthyAge7™ complex (kidney, coat, vitality, appetite/weight, digestion, brain/vision, immunity).
- Genetic screening can now identify mutations linked to urinary stones, obesity, and hepatic copper accumulation; Royal Canin is combining multi-omics with AI to decode metabolic pathways. Its weight + urinary multi-condition diet tackles two historically conflicting goals in one formula; 3 multi-condition prescription diets are already on the China market.
Breakthrough 2 — Manufacturing
The “dual-factory” layout pairs the Shanghai plant (operational since 2010, Fengxian District) with the Tianjin plant, whose first wet-can line opened end of 2025: creating a “north-south, dry-wet” synergy. The Tianjin line already fields 5 China-customized small wet cans (puppy/kitten, adult cat, breed-specific) with 10 more coming (senior, adult, disease-stage).
- Quality system: >RMB 10M/yr testing, 70% on raw materials; every raw-material sample retained 2 years for traceability; Shanghai plant is under audit ~one third of the year.
- Two validation gates before mass production: send to France HQ for digestibility/palatability sign-off by master formulators, plus ≥40 tests on the first 5 batches at the Asia-Pacific lab.
- Verified milestone: The Shanghai plant was named a World Economic Forum “Lighthouse Factory” on 22 June 2026 — the first in the global pet industry, and in the “Customer-centric” category (only 8 worldwide). It deploys 40+ Industry 4.0 solutions with AI-driven process control. (Confirmed by Xinhua, China News Service Shanghai, China News Weekly, and Eastday.)
Breakthrough 3 — Ecosystem
Corporate Affairs Director Vivian framed pet health as a shared ecosystem (breeders, pet stores, vets, rescuers, platforms, associations, media, government). Royal Canin:
- Co-drafted (Pet Dog & Cat Trade Management Specification), China’s first normative document for the full pet-trade process, released during Asia Pet Fair; Royal Canin has now co-drafted 6 standards.
- With the China Veterinary Medical Association, ran the 2nd offline seminar of the “Pet Nutrition Expert Pool.”
- With JD Health, launched prescription-diet standard advocacy and a new product, aligning as a JD platform admission benchmark for prescription food.
- Ran the “Its Nutrition Universe” immersive brand exhibition in Shanghai, Beijing, Shenzhen, and Chengdu (21–23 Aug), with free vet clinics, and a Tmall Super Brand Day human-pet story corridor at Shanghai Xujiahui metro (17–23 Aug).
GlobalPetIndex takeaway
Royal Canin is doubling down on China: a first-of-its-kind smart factory, a fast-expanding wet-food line, and aggressive standard-setting across trade, nutrition, and prescription diets. For the Asian pet-food competitive set (see our companion piece on Asia’s top 10), the signal is clear — the premium / scientific-nutrition segment is consolidating around players that can combine R&D depth, manufacturing maturity, and ecosystem influence. B2B buyers should watch Royal Canin’s Tianjin wet-food capacity and its prescription-diet platform standards as markers of where premium channel requirements are heading.
Sources & verification
- WEF Lighthouse Factory (Shanghai, first in global pet industry): Confirmed across Xinhua (2026-06-24), China News Service Shanghai (2026-06-23), China News Weekly (2026-06-26), and Eastday (2026-08-21). WEF announced the list on 22 June 2026; “Customer-centric” category has only 8 worldwide; Royal Canin is part of Mars, Inc. . Factory in Fengxian, Shanghai, operational since 2010.
- 2026 Brand Summit in Shanghai (20 Aug 2026): Confirmed by Eastday’s republication of the article. Speakers (Xu Juan, Yann Queau, Xiao Lei, Vivian) consistent across sources.
- 58-year history / founded 1968: Accurate — Royal Canin founded 1968 in Gard, France, by Jean Cathary.
- 600+ global formulas / 350+ for China, Tianjin wet line end-2025, co-drafted 6 standards, JD Health partnership: Consistent with the article and corroborating coverage (xfrb.com.cn, eastday). Treated as reported.
- Clinical HCM study specifics (44 cats, biomarkers, <6mm wall thickness): Presented as Royal Canin’s reported clinical data; not independently re-verified here.
Related Market Insight
See also: Asia’s Top 10 Pet Food Companies by Revenue — 2026 Ranking — the full Asia top-10 pet food revenue ranking and supply-chain map. (GlobalPetIndex Market Insight)
